AZD6234
A Trial to Assess the Relative Bioavailability of Different Subcutaneous Formulations of AZD9550 and AZD6234
AstraZeneca · Phase 1 · Not yet recruiting · Enrollment 60
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.